Meghan V. Joyce - 04 Jul 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John G. Saia, as attorney-in-fact for Meghan Verena Joyce
Issuer symbol
GH
Transactions as of
04 Jul 2024
Transactions value $
$0
Form type
4
Filing time
08 Jul 2024, 17:29:37 UTC
Previous filing
13 Jun 2024
Next filing
05 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +66 +0.65% $0 10,279 04 Jul 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -66 -7.1% $0 863 04 Jul 2024 Common Stock 66 $0 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit vests as to 25% of the shares subject to such award on August 4, 2022, and as the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter.
F2 Not applicable for Restricted Stock Units.